The Texas Law Firm of Nachawati Law Group continues its investigation concerning a potential Digitek and Digoxin lawsuit on behalf of people suffering from digitalis toxicity and other side effects including nausea, vomiting, dizziness, low blood pressure, irregular heartbeat, and possible death. The manufacturer and distributor of the defective drug include Actavis Totowa, Mylan Pharmaceuticals, Bertek, and UDL Laboratories. The drug’s primary purpose is to treat conditions such as congestive heart failure and atrial fibrillation. However, a recent nationwide recall has been issued because of the possibility that Digoxin tablets may contain double the appropriate thickness in each tablet. In other words, some Digoxin pills contain two times the FDA approved level of active ingredient. The active ingredient in Digitek can cause digitalis toxicity, especially people suffering from renal failure. A Digitek overdose can also result in death.
———
About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact or call 214-890-0711.
